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Abstract
The WHO says that annual cases of cancer will increase from 14 million in 2012 
to 22 million in the next two decades. Cancer is the second cause of death in the 
world; in 2015, it caused 8.8 million deaths. On the other hand, it is necessary to 
consider that 70% of the total deaths due to this disease occur in developing coun-
tries, who have the least resources to acquire the drugs of choice for the treatment 
of this disease. Although there are treatments and these are effective, there are 
currently cases of resistance to drugs used to treat this disease, which has led to the 
search for new sources of drugs or compounds effective against the cancer being 
active; plants are the possible sources to achieve this. Cucurbitaceae is a family of 
plants widely distributed on the planet which has been used traditionally for the 
treatment of this disease and from they have been isolated different cucurbitanes. 
These compounds possess a wide biological activity, antidiabetic, anti-inflamma-
tory, hepatoprotective, or cytotoxic and antitumoral effects. The aim of this review 
is to present 51 cucurbitacin compounds and 2 with different structures isolated 
from Cucurbitaceae plants with cytotoxic or antitumoral activity.
Keywords: cucurbitacin, Cucurbitaceae, cytotoxic, cancer, natural product
1. Introduction
Cancer is an abnormal growth of cells, which begin to divide without stopping 
and can form solid tumors. Cancer is a collection of more than 100 different dis-
eases with genetic changes, which can be inherited or be caused by environmental 
exposure to chemicals, tobacco smoke, or radiation, such as UV rays from the sun.
Cancer is the second leading cause of death in the US and is responsible for 
approximately 1 out of every 4 deaths. Globally, nearly 1 in 6 deaths is due to cancer. 
Approximately, 70% of deaths from cancer occur in low- and middle-income coun-
tries. There were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 
million people living with cancer (within 5 years of diagnosis) in 2012 worldwide, 
based on World Health Organization (WHO) estimates. A total of 57% (8 million) 
of new cancer cases, 65% (5.3 million) of cancer deaths, and 48% (15.6 million) of 
5-year prevalent cancer cases occurred in less-developed regions [1, 2].
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The most common treatments for cancer are surgery, chemotherapy, and radia-
tion therapy, and in many cases, they are used in combination [3]. These treatments 
can be effective but can cause side effects, such as anemia, appetite loss, fatigue, 
and alopecia [4].
1.1 Generalities of the Cucurbitaceae family
Plants are an important source of compounds currently used in cancer chemo-
therapy. The Cucurbitaceae family, also called cucurbits, contains 120 genera with 
825 species that are widely distributed in tropical and temperate regions [5], and 
those with edible fruits were the first cultivated plants in Europe and America. 
Many species of the Cucurbitaceae family are used as human food [6]. Most of the 
species in this family are annual vines, and some are lianas, thorny shrubs, or trees. 
The most important genera of this family are Cucurbita (squash, pumpkin, zuc-
chini), Lagenaria (calabash), Citrullus (watermelon), Cucumis (cucumber, various 
melons), and Luffa (luffa).
1.2 Cucurbitanes of the Cucurbitaceae family with cytotoxic effects
Some cucurbitanes have been isolated from different species of the 
Cucurbitaceae family. These compounds exhibit an extensive range of biological 
actions, specifically antidiabetic, anti-inflammatory, cytotoxic, hepatoprotective, 
cardiovascular, and antiparasitic effects [7].
Cucurbitacins are characteristic compounds in many species of cucurbits. These 
compounds are tetracyclic triterpenes arising from a rearrangement of the proto-
stane cation and are unsaturated and polyfunctional oxygenated compounds and 
occur most often as glycosides. They are particularly toxic and bitter chemicals, and 
their cytotoxicity contributes to their toxicity [8]. Cucurbitanes are found in many 
plants.
The most significant mechanisms of the apoptotic effects of cucurbitacins are 
their ability to modify the mitochondrial transmembrane potential and transcrip-
tional activity via nuclear factors or genes and their ability to activate or inhibit 
pro- or antiapoptotic proteins.
Similar to other plant-derived compounds, cucurbitacins exert toxic effects 
in different cancer cell lines by inducing apoptosis. The main mechanism of this 
induction is the ability to modify the mitochondrial transmembrane potential [6].
Therefore, some compounds obtained from Cucurbitaceae could be useful 
scaffolds for developing new drugs. We consider it necessary to review the main 
chemicals from this genus with potential anticancer activity.
2. Cucurbitacins tetracyclic triterpenoids
Cucurbitacins are primarily tetracyclic triterpenoids (Figure 1) that compose a 
class of biochemical compounds contained in plants of the family Cucurbitaceae, 
which include the Thai medicinal plants Trichosanthes cucumerina L. and T. kirilowii 
Maximowicz, the leaves and fruits of the Tunisian plant Ecballium elaterium; the 
fruits of Cucurbita pepo cv. dayangua; the roots of Cayaponia tayuya (Tayuya), which 
has long been used in folk medicines from Brazil, Peru, and Colombia; C. racemosa 
Cong., the roots of Hemsleya amabilis, an ancient Chinese remedy, Cucumis melo L., 
Momordica balsamina L. (balsam pear), Cucurbita andreana (winter squash), and 
Citrullus colocynthis (bitter cucumber). Below, the most important cucurbitacins that 
have shown interesting cytotoxicity and anticancer activity are listed.
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2.1 Cucurbitacin B (1′)
Cucurbitacin B (CuB) is an oxygenated tetracyclic triterpenoid compound (1′). 
The growth-inhibiting effect of CuB was evaluated on MCF-7 and MDA-MB-231 
breast cancer cells and B16F10 melanoma cells by the MTT assay. This compound 
had antiproliferative effects against breast cancer cells in a dose-dependent manner, 
and the IC50 values for MCF-7 and MDA-MB-231 were 4.12 and 3.68 μM,  
respectively [9].
CuB potently suppressed the growth of four types of NSCLC cells (H1299, A549, 
HCC-827, and H661), inhibiting the proliferation of all the cell lines with IC50 values 
between 0.05 and 0.130 μM. The mean tumor volume at the end of the study in 
CuB-treated mice was 200 ± 111 mm3, compared to 684 ± 321 mm3 in the control 
group (average reduction of 70% in tumor volume (p < 0.05). No visible sign of 
toxicity was observed in CuB-treated mice [10]. CuB could suppress human NSCLC 
cell growth in vitro through its effects on the PI3Kinase and MAPK pathways, which 
lead to programmed cell death induction, as well as inhibition of cell migration and 
cell invasion [11]. Additionally, CuB induces cell cycle arrest in A-549 cells and causes 
DNA double strand breaks. It also produces DNA damage and G2/M phase arrest; this 
damage could be due to an increase in reactive oxygen species (ROS) formation [12].
The cytotoxic effect of CuB was tested on HeLa and U2OS cells, and the IC50 
values were 12.2 and 17.07 μM, respectively. The inhibition of tubulin polymer-
ization in vitro was observed with an IC50 > 1 mM [13]. CuB from the leaves of 
Tunisian E. elaterium exhibited an anticancer effect and displayed anti-integrin 
activity in human glioblastoma U87 cells, with no cytotoxicity observed at con-
centrations up to 500 nM. CuB affected the adhesion and migration of U87 cells to 
fibronectin with IC50 values of 86.2 and 84.6 nM, respectively. Time-lapse video-
microscopy showed that CuB significantly reduced U87 cell motility and affected 
directional persistence. CuB also inhibited cell proliferation with an IC50 value of 
70.1 nM, as determined using the crystal violet assay. Moreover, CuB inhibited 
in vitro human microvascular endothelial cell (HMEC) angiogenesis at concentra-
tions up to 10 nM. Interestingly, this work demonstrated for the first time that this 
effect was specifically mediated by α5β1 integrins. These findings reveal a novel 
mechanism of action for cucurbitacin B, which displays potential as a specific anti-
integrin drug [14].
Figure 1. 
General structure of cucurbitacin tetracyclic triterpenoid.
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2.2 23,24-Dihydrocucurbitacin B (DHCB) (2′)
C. tayuya (Cucurbitaceae) is a climbing lignified plant with a large tuber that has 
long been used in folk medicine as an anti-inflammatory, antitumor, and antirheu-
matic agent. DHCB (2′) was isolated from the roots of C. tayuya and assessed in 
isogenic colon cancer cell lines HCT116 and Hke-3 by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. This compound induced 
apoptosis in both cell lines with IC50 values of 9.8 and 4.7 μM, respectively [15].
DHCB inhibited the viability of human cervical cancer cell lines with an IC50 of 
40–60 μM, but its cytotoxic effects were less pronounced in normal epithelial fr2 
and HerEpiC cells, where the IC50 was 125 μM. The underlying mechanisms were 
studied, and the results showed that DHCB induced apoptosis in HeLa cells and 
caused ROS-mediated shifts in the ΔΨm. Additionally, DHCB caused cell cycle 
arrest in HeLa cells at the G2/M checkpoint. The phosphoinositide 3 kinase/protein 
kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR) cascade may play an 
important role in cancer tumorigenesis and progression and resistance to chemo-
therapy. The results indicated that DHCB decreased the expression of important 
proteins in the PI3K/Akt/mTOR cascade [16].
2.3 23,24-Dihydrocucurbitacin F (DHCF) (3′)
DHCF (3′) has been isolated from the roots of H. amabilis, an ancient Chinese 
remedy for bacillary dysentery, gastroenteritis, and cancer. While the toxicity of 
other cucurbitacins has been explored in several types of cancer, little data exist on 
the effect of DHCF on human cancers, including prostate cancer (PCa). Human 
PCa DU145, PC3, and LNCaP cells were treated with graded doses of DHCF 
in vitro, and the antiproliferative activity of this compound was determined using 
the MTS assay. DHCF inhibited the proliferation of all three PCa cell lines in a dose-
dependent manner. The IC50 values of DHCF in DU145, PC3, and LNCaP cells were 
15, 7, and 5 μM, respectively [17].
2.4 Cucurbitacin E (4′)
The inhibition of breast cancer metastasis in mouse models by CuE was 
reported. To evaluate the effect of CuE on the proliferation and apoptosis of 
inoculated 4T1 and MDA-MB231 cells in vivo, the expression of proliferating cell 
nuclear antigen (PCNA) and cleaved caspase-3 was tested by immunohistochemical 
analysis [18]. CuE targets the dissemination of breast cancer cells from the primary 
tumor but not the outgrowth of established micrometastases in target organs (lung, 
liver, between others). CuE exerts no significant effect on tumor cell apoptosis or 
proliferation in vivo [19].
CuE demonstrated cytotoxic activity against human oral squamous cell carci-
noma SAS cells with an IC50 of 3.69 μM and induced the apoptosis of SAS cells after 
24 h of treatment, but not MRC-5 or HS68 cells, which showed a dose-dependent 
reduction. Microscopic examination showed that following exposure to CuE 
(2.5 μM) for 6–24 h, the cells displayed a remarkable change in their morphology, 
and CuE induced the death of cancer cells [20].
The inhibitory effect of CuE on the proliferation of Bcap37 and MDA-MB-231 
cells was assessed by the MTT assay. Breast cancer cells were treated with various 
concentrations (0, 0.1, 1, 10, and 100 μM) of CuE or DMSO as a control for 24, 
48, and 72 h. The MTT method was then used to determine the number of viable 
cells. The data indicated that CuE inhibited cell growth in a concentration- and 
time-dependent manner (ANOVA, p < 0.05). After treatment with 0.1 μM CuE for 
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24 h, the growth of Bcap37 and MB-231 cells was significantly inhibited. At a CuE 
concentration of 100 μM, most of the cancer cells detached from the dish [21].
Additionally, CuE was evaluated on the chondrosarcoma SW 1353 cancer cell 
line, and the IC50 values indicated higher toxicity in this cell line than in the previ-
ously test lines (MTT assay). The amount of CuE that induced a mortality of 50% 
was calculated after 6, 12, and 24 h of treatment, and the results were 13.55, 12.65, 
and 9.16 μM, respectively [22]. The cytotoxic effect of CuE was tested on HeLa and 
U2OS cells, and the IC50 values were 6.43 and 15.07 nM, respectively. The inhibition 
of tubulin polymerization in vitro had an IC50 of 566.91 nM [13].
The effects of CuE from E. elaterium fruit on the expression of the BAX, 
caspase-3, LC3, and VEGF and c-MYC genes in the AGS cell line were investi-
gated. The sub-G1 accumulation of AGS cells treated with CuE was increased 
compared to that of untreated cells. Moreover, the treatment of AGS cells with 
CuE-induced cell death. Additionally, the effects of CuE on the mRNA expres-
sion levels of the LC3, VEGF, BAX, caspase-3, and c-MYC genes were evaluated 
using qRT-PCR. LC3 mRNA levels were increased approximately 20-fold after 
treatment with CuE at a concentration of 0.1 μg/mL for 24 h. However, BAX, 
caspase-3, and c-MYC mRNA levels at these concentrations were not changed by 
the treatment [23, 24].
2.5 Cucurbitacin R (5′)
One additional cucurbitacin was discovered in the roots of C. tayuya and was 
identified as cucurbitacin R (CCR) (5′). This compound was experimentally 
assessed in isogenic colon cancer cell lines HCT116 and Hke-3 by the MTT assay 
and induced the apoptosis of both HCT116 and Hke-3 cells with IC50 values 37 and 
27 μM, respectively [15].
2.6 Cucurbitacin I (6′)
CuI, also known as elatericin B or JSI 124, has been isolated from different 
plants, such as M. balsamina L. (balsam pear), C. tayuya (tayuya), Cucurbita 
andreana (winter squash), and C. colocynthis (bitter cucumber). This compound 
was tested in isogenic colon cancer cell lines HCT116 and Hke-3 and was found 
to induce apoptosis in both lines, with IC50 values of 0.29 and 0.09 μM, respec-
tively [15].
The cytotoxicity IC50 values of CuI in SW 1353 cells after 6, 12, and 24 h of treat-
ment were 7.93, 8.31, and 5.06 μM, respectively [22]. The cytotoxic activity of CuI 
against SW-480 human colon cancer cells was tested. In this case, CuI diminished 
cell proliferation in a concentration-dependent manner and increased apoptosis, 
enhancing cycle arrest at the G2/M phase [25].
The cytotoxicity of CuI was tested in HeLa and U2OS cells, and the IC50 values 
were 44.77 and 23.47 nM, respectively. The inhibition of tubulin polymerization 
in vitro had an IC50 > 1 mM [13]. The effects of CuI purified from E. elaterium fruit 
on the expression of the BAX, caspase-3, LC3, and VEGF and c-MYC genes in the 
AGS cell line were investigated. The sub-G1 accumulation of AGS cells treated with 
CuI was increased compared to that of untreated cells. Moreover, treatment of AGS 
cells with CuI-induced cell death. Additionally, the effects of CuI on the mRNA 
expression levels of the LC3, VEGF, BAX, caspase-3, and c-MYC genes were evalu-
ated using qRT-PCR. After treatment, at a concentration of 0.5 μg/mL for 24 h, LC3 
mRNA levels were increased approximately 25-fold, and VEGF mRNA levels were 
increased approximately 4.4-fold. However, BAX, caspase-3, and c-MYC mRNA 
levels were not considerably changed after treatment with CuI [23, 24].
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2.7 Cucurbitacin D (7′)
CuD was evaluated in the chondrosarcoma SW 1353 cancer cell line. Its IC50 
values against SW 1353 cells after 6, 12, and 24 h of treatment were 16.48, 13.03, and 
13.14 μM, respectively [22].
The effects of CuD purified from E. elaterium fruit on the expression of the 
BAX, caspase-3, LC3, VEGF, and c-MYC genes in the AGS cell line were inves-
tigated. The sub-G1 accumulation of AGS cells treated with CuD was increased 
compared to that of untreated cells. Moreover, the treatment of AGS cells with 
CuD induced cell death. Additionally, the effects of cucurbitacin D on the mRNA 
expression levels of the LC3, VEGF, BAX, caspase-3, and c-MYC genes were evalu-
ated using qRT-PCR. LC3 mRNA levels were increased approximately 23-fold after 
treatment with CuD at a concentration of 0.3 μg/mL for 24 h. However, the BAX, 
caspase-3, and c-MYC mRNA levels were not considerably changed after treatment. 
Regarding the effects of CuD and CuE on LC3 mRNA expression, CuD’s effect was 
significantly greater than that of CuE [23].
2.8 Cucurbitacin A (8′)
The antiproliferative effects of Cucurbitacin A (CuA) on A-549 cells were 
determined by using the MTT assay. This compound exhibited a potent cytotoxic 
effect on A-549 cells. The assay was carried out at different concentrations of CuA 
(0, 10, 20, 40, 100, 150, and 200 μM) with incubation for 24 and 48 h. CuA showed 
inhibitory effects on cell proliferation in a dose- and time-dependent manner. 
However, the effect of the incubation time was more pronounced at higher doses of 
the compound. CuA also induced morphological changes in these cells, featuring 
chromatin condensation, cell shrinkage, and apoptotic body formation. G2/M phase 
cell cycle collapse was also induced by CuA along with inhibition of the expression 
levels of m-TOR/PI3K/Akt proteins [26].
2.9 2 β,3β,16α,20(R),25-Pentahydroxy-22-oxocucurbita-5-en (RPO) (9’)
This compound is a cucurbitacin isolated from Cayaponia racemosa Cong. 
The anticancer activity of RPO was evaluated with in vitro and in vivo models. 
Cucurbitacin (9′) reduced the number of viable HL-60 leukemia cells; however, 
there was no change in the number of nonviable cells at 5 μg/mL. This compound 
had no effect on normal proliferating lymphocytes at the concentrations tested 
(IC50 > 25 μg/mL). Morphological analysis of RPO-treated cells showed typical 
apoptotic features, such as heavy deposition of granules in the cytoplasm (eosino-
philia), DNA fragmentation and irregularities in the plasma membrane, and intense 
vacuolization and disruption of the plasma membrane. Acridine orange/ethidium 
bromide staining confirmed these findings, revealing an increased number of 
apoptotic cells. In the sarcoma 180 tumor model, compound (9′) showed 52 or 62% 
antitumor activity when administered alone (25 mg/kg/day) or in association with 
the chemotherapeutic agent 5-FU (10 + 10 mg/kg/day), respectively. Moreover, 
treatment with compound (9′) either alone or in combination with 5-FU caused an 
increase in spleen weight and morphological alterations related to immunostimula-
tory properties [27].
2.10 Cucurbitaglycosides A (10′) and B (11′)
Phytochemical investigation of the fruits of Cucurbita pepo cv. dayangua led to 
the isolation of cucurbitaglycosides A (10′) and B (11′). This was the first report of 
7Cytotoxic and Antitumoral Activities of Compounds Isolated from Cucurbitaceae Plants
DOI: http://dx.doi.org/10.5772/intechopen.82213
cucurbitane triterpenoids with a purine unit. Cucurbitaglycosides A and B showed 
cytotoxic activity against the human epithelial carcinoma cell line HeLa with IC50 
values of 17.2 and 28.4 μg/mL, respectively [28].
2.11 Hemslecin A (12′)
Three cucurbitane triterpenoids were isolated from H. amabilis, and the 
main compound was Hemslecin A (HA). This compound showed significant 
cytotoxic activity against HeLa cells with an IC50 value of 0.389 μM. Additionally, 
7β-hydroxycucurbitacin F-25-O-acetate (13′) and 2β,3β,20(S),26,27-pentahydroxy-
16α,23(S)-epoxycucurbita-5,24-dien-11-one (14′) (Figure 2) were isolated and 
showed less cytotoxic activity (IC50 values of 12.3 and 387 μM, respectively) than 
HA [29].
3. Cucurbitane-type triterpene glycosides
Several new cucurbitane-type triterpene glycosides (Figures 3 and 4) have been 
isolated from the fruit pulp of Momordica charantia L., and their cytotoxic activity 
has been evaluated.
Two new cucurbitane-type triterpene glycosides, charantagenins D (15′) and E 
(16′), and one new sterol, 7-oxo-stigmasta-5, 25-diene-3-O-β-D-glucopyranoside 
(17′), were isolated from the fruit of M. charantia L. together with another six 
known compounds (18′–23′). The cytotoxic activities of the major isolated 
compounds were evaluated against the lung cancer cell line A549, glioblastoma 
cell line U87, and hepatoma carcinoma cell line Hep3B using in vitro MTT 
assays. Two new cucurbitane-type triterpenes, 25-methoxycucurbita-5,23(E)-
diene-3β,19-diol (24′) and 7β-ethoxy-3β-hydroxy-25-methoxycucurbita-
5,23(E)-dien-19-al (25′), together with three known cucurbitane-type 
triterpenes, 3β,7β,25-trihydroxycucurbita-5,23(E)-dien-19-al (26′), (23E)-3β-
hydroxy-7β,25-dimethoxycucurbita-5,23-dien-19-al (27′), and 3β-hydroxy-
25-methoxycucurbita-6,23(E)-dien-19,5β-olide (28′), were isolated from the 
fruit pulp of M. charantia. Their cytotoxic activity was evaluated against human 
hepatoma SK Hep-1 cells with etoposide as a positive control (IC50 = 3.7 μM). The 
results are shown in Table 1 [19, 30].
3.1 Momordicin VII (29′)
Several new cucurbitane triterpenoids were isolated from the stems and leaves of 
M. charantia and tested against five human cancer cell lines (HL-60, SMMC-7721, 
A-549, MCF-7, and SW480). Only momordicin VII (29′) was slightly active, with 
IC50 values of 16.2, 20.3, 20.5, 16.9, and 14.3 μM, respectively [31].
Figure 2. 
2β,3β,20(S),26,27-Pentahydroxy-16α,23(S)-epoxycucurbita-5,24-dien-11-one.
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Figure 4. 
Structure of cucurbitane-type triterpene glycosides 20’, 22’, 23’, 28’.
Figure 3. 
Structure of cucurbitane-type triterpene glycosides 15’, 17’-19’, 21’, 24’-29’.
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4. Multiflorane-type triterpenes
Multiflorane-type triterpenes (Figure 5), a new class of cucurbitacins, were 
isolated from seeds of Cucurbita maxima, along with three known compounds from 
Benincasa hispida (Thunb.) Cogn., fruits that are widely consumed in China and 
tropical countries, and these compounds were found to exhibit interesting cytotox-
icity activity.
Three new multiflorane-type triterpenes, 7α-methoxymultiflor-8-ene-3α, 
29-diol-3-acetate-29-benzoate (30′), 7-oxomultiflor-8-ene-3α,29-diol-3-acetate- 
29-benzoate (31′), and multiflora-7,9(11)-diene-3α,29-diol-3-p-hydroxybenzoate-29- 
benzoate (32′), were isolated from seeds of C. maxima, along with three known 
compounds. These compounds exhibited cytotoxicity against HL-60 and P388 
cells. Compound (30′) did not show significant cytotoxic activity, with an 
IC50 > 100 μM in both lines, but compounds 31 and 32 showed cytotoxic activity 
against HL-60, with IC50 values of 7.1 and 7.1 μM, respectively. The IC50 values for 
P388 were 55.9 and 92.6 μM, respectively [32].
Analysis of Benincasa hispida (Thunb.) Cogn. fruits yielded three new trit-
erpenoids, 3α,29-O-di-trans-cinnamoyl-D:C-friedooleana-7,9(11)-diene (33′), 
oleanolic acid 28-O-β-D-xylopyranosyl-[β-D-xylopyranosyl-(1→4)]-(1→3)-α-
L-rhamnopyranosyl-(1→2)-α-L-arabinopyranoside (34′), and oleanolic acid 
28-O-β-D-glucopyranosyl-(1→3)-β-D-xylopyranosyl-[β-D-xylopyranosyl-
Cancer cell line IC50 values (μM)
A549 lung cancer cell line 15′ = 1.07
16′ = 3.82
17′, 22′, 23′ = >100
18′ = 4.46
19′ = 4.89
20′ = 5.32
21′ = 15.10
U87 glioblastoma cell line 15′ = 1.08
16′ = 67.32
17′,18′,22′,23′ = >100
19′ = 0.60
20′ = 0.19
21′ = 8.65
Hep3B hepatoma carcinoma cell line 15′ = 14.01
16′–19′,21′–23′ = >100
20′ = 19.30
SKHep1 human hepatoma cell line 24′ = 33.1
25′ = 24.3
26′ = >50
27′ = >13
28′ = 38.7
Table 1. 
Cytotoxic activities of cucurbitane-type triterpene glycosides 15′–28’.
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(1→4)]-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranoside (35′). The 
cytotoxic activities of compounds (33′−35′) were assessed by the MTT assay. 
These compounds showed no significant cytotoxic activity against HeLa human 
cervical, HL-60 human hepatoma, and SMMC-7721 human hepatoma cell  
lines [33].
5. Cyclic bisdesmosides
Cyclic bisdesmosides, new compounds analogous to cucurbitacins, share the 
tetracyclic triterpenoid core but contain carbohydrates to form a bicycle (Figure 6).  
These compounds were isolated from Actinostemma lobatum MAXIM and 
Bolbostemma paniculatum (Maxim) Franquet.
Two new cyclic bisdesmosides elucidated as lobatoside L (36′) and lobatoside M 
(37′) and four known cyclic bisdesmosides (38′–41′) were isolated from A. lobatum 
Maxim. The inhibitory effects of these six compounds on human cancer cell growth 
(including the esophageal squamous carcinoma cell line ECA109, lung cancer cell 
line A549, and gastric cancer cell line MGC-803) were determined using the MTT 
assay. The six compounds exhibited cytotoxicity against all the cell lines tested, and 
compounds (36′, 38′, and 40′) showed significant activity in a dose-dependent 
manner against all the cell lines. The IC50 values for compounds (36′ and 40′) 
against ECA-109 cells were 8.25 and 3.71 μM, respectively. The rest of the results are 
shown in Table 2 [34].
Tubeimoside I (42′) isolated from B. paniculatum (Maxim) Franquet exhibited 
cytotoxic activity against HepG2 human cancer cells. The IC50 values at different 
times of exposure (24, 48, and 72 h) were 15.5, 11.7, and 9.2 μM, respectively. This 
compound induced shrinkage, nuclear condensation, fragmentation, and cell cycle 
arrest in phase G2/M. The inhibition of growth in this case is mediated by a cascade 
of apoptosis [35].
Figure 5. 
Multiflorane-type triterpenes.
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Figure 6. 
Cyclic bisdesmosides structure.
Cancer cell lines IC50 values (μM)
Esophageal squamous carcinoma cell line ECA-109 36′ = 8.25
37′ = 74.14
38′ = 22.37
39′ = 71.97
40′ = 3.71
41′ = 83.53
Lung cancer cell line A549 36′ = 26.52
37′ = 69.28
38′ = 27.27
39′ = 77.79
40′ = 35.12
41′ = 77.02
Gastric cancer cell line MGC-803 36′ = 35.33
37′ = 84.71
38′ = 36.85
39′ = 90.49
40′ = 35.21
41′ = 96.55
Table 2. 
Cytotoxic activities of cyclic bisdesmosides 36′–41’.
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6. Gypenosides
The gypenosides (Figure 7) were isolated from Gynostemma pentaphyllum and 
from the aerial parts of G. pentaphyllum.
Gypenoside L (43′) and gynogenin (44′), 20(S)-dammar-24-en-2a,3b,12b,20-
tetrol, were isolated from G. pentaphyllum and tested against A-549 lung carci-
noma cells. The IC50 values were 34.94 and 12.54 μg/mL, respectively [36]. Some 
gypenosides were isolated from the aerial parts of C. pentaphyllum (45′–51′), and 
their structures were elucidated with spectroscopic and chemical methods. Their 
cytotoxic activity was determined against different human cancer cell lines, A549, 
HT-29, MCF-7, and SK-OV-3. All the compounds showed low activity, with IC50 
values between 62.8 and 19.6 μM [37].
7. Other substances of interest
In addition to the cucurbitacins, other substances isolated from the 
Cucurbitaceae family have been identified, including proteins isolated from the 
sarcocarp of Cucurbita moschata (pumpkin) and from the root of T. kirilowii Maxim 
Figure 7. 
Gypenosides structure.
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(Cucurbitaceae). Additionally, the protein from the root of T. kirilowii Maxim has 
been demonstrated to possess important cytotoxicity activity.
7.1 Cucurmosin
A novel type-1 ribosome-inactivating protein (RIP) designated cucurmosin was 
isolated from the sarcocarp of Cucurbita moschata (pumpkin). Its structure contains 
two domains: a large N-terminal domain composed of seven α-helices and eight 
β-strands and a smaller C-terminal domain consisting of three α-helices and two 
β-strands (Figure 8).
Cucurmosin was tested for its cytotoxicity against human leukemia cells (K562), 
murine melanoma cells (B16), lung adenocarcinoma cancer cells (A549), and periph-
eral blood lymphocytes using the standard MTT assay. The IC50 values of cucurmosin 
were 88.1, 63.4, and 359.3 nM in human leukemia cells (K562), murine melanoma 
cells (B16), and lung adenocarcinoma cancer cells (A549), respectively, while its IC50 
in normal cells (peripheral blood lymphocytes) was higher than 1.4 μM [38].
7.2 Trichosanthin
Trichosanthin was isolated from the roots of T. kirilowii Maxim and has been 
used in traditional Chinese medicine. This compound was tested against HepG-2 
and WRL 68 cells, and the IC50 values obtained were 10.38 and 15.45 μmol/L, 
respectively [39].
Tianhua, an extract of T. kirilowii, was analyzed to determine its mechanism 
of action against lung cancer cells (A549) using the MTS assay. This compound 
induced apoptosis via an anti-telomerase effect but had no effect on stimulating 
peripheral lymphocytes to produce interferon (IFN)-γ; tianhua inhibited the 
metastatic ability of cells and inhibited the growth of cancer cells in vivo [40].
8. Conclusion
The aim of this review is to present 51 cucurbitacin compounds and two com-
pounds with different structures isolated from Cucurbitaceae plants, their chemical 
structures, their biological activities, and the mechanisms by which these com-
pounds reduce the proliferation of cancer cells.
Figure 8. 
Overall structure of cucurmosin in stereo view.
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